Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC [Phase 2]
A Phase 2 clinical trial comparing ABX plus cisplatin against gemcitabine plus cisplatin in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer [Phase 2]
This entry reports the completion of a Phase 2 clinical trial evaluating gemcitabine as maintenance therapy in patients with advanced non-sm…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer [Phase 3]
Phase 3 AVAPERL1 trial evaluating bevacizumab with or without pemetrexed as maintenance after first-line therapy in non-squamous non-small c…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer [Phase 2]
Phase 2 trial results suggest that thymidylate synthase gene polymorphism may predict treatment effect in patients with advanced lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer [Phase 2]
An exploratory Phase 2 study of QBKPN SSI in non-small cell lung cancer has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments [Phase 2]
Phase 2 trial comparing best supportive care plus E7080 versus best supportive care alone in previously treated advanced non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09 [Phase 2]
Phase 2 trial update on hypofractionated 3-Dimensional radiation therapy for newly diagnosed stages I-III non-small cell lung cancer (ICORG …
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating proton radiation therapy with cisplatin and etoposide followed by surgery in stage III non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients [NA]
Clinical trial update on the combination of nimotuzumab with paclitaxel liposome and carboplatin (the TP regimen) for advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)
The study evaluating serum thioredoixn reductase activity in excised non-small cell lung cancers across stages I, II, and IIIA has completed…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Correlation Research of Thioredoxin Reductase in Lung Cancer
Completed clinical trial investigating correlations of thioredoxin reductase in lung cancer, including non-small cell lung cancer and benign…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone [Phase 3]
Phase 3 trial evaluating IRESSA beyond progression plus chemotherapy versus chemotherapy alone in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL) [Phase 2]
Phase 2 trial of dichloroacetate (DCA) in previously treated metastatic breast cancer and non-small cell lung cancer was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase 1/2 trial of alectinib in ALK-rearranged non-small cell lung cancer completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: BATTLE Program: Sorafenib in Patients With NSCLC [Phase 2]
The BATTLE program's Phase 2 study of sorafenib in non-small cell lung cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial results evaluating the combination of erlotinib and bevacizumab in chemotherapy-naïve non-small cell lung cancer patients with…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients [Phase 2]
A Phase 2 randomized trial comparing gefitinib with pemetrexed in patients with previously treated metastatic non-small cell lung cancer has…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer [NA]
Clinical trial evaluating apricoxib, a selective COX-2 inhibitor, for modulating regulatory T cells in patients with early-stage non-small c…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy [Phase 2]
This Phase II trial of the epothilone analog BMS-247550 in patients with non-small cell lung cancer after failure of first-line platinum-bas…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
This document reports the completion of a Phase 1 trial of BAY 43-9006 (sorafenib) in patients with previously untreated non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating cisplatin/etoposide with radiotherapy, with optional consolidation docetaxel, in advanced stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients
The Vanguard Study for head and neck cancer and non-small cell lung cancer has completed enrollment and the document provides a status updat…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating safety and efficacy of buparlisib (BKM120) in patients with metastatic non-small cell lung cancer; results posted i…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients [Phase 4]
Phase 4 trial evaluating CYP3A4 and CYP1A2 phenotyping to tailor Sunitinib or Erlotinib therapy in cancer patients, including non-small cell…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations [Phase 4]
Phase 4 study results reported for erlotinib (Tarceva) as first-line therapy in patients with locally advanced or metastatic EGFR-mutant non…